Kohls, Mirjam
Freisling, Heinz
Charvat, Hadrien
Soerjomataram, Isabelle
Viallon, Vivian
Davila-Batista, Veronica
Kaaks, Rudolf
Turzanski-Fortner, Renée
Aleksandrova, Krasimira
Schulze, Matthias B.
Dahm, Christina C.
Tilma Vistisen, Helene
Rostgaard-Hansen, Agnetha Linn
Tjønneland, Anne
Bonet, Catalina
Sánchez, Maria-Jose
Colorado-Yohar, Sandra
Masala, Giovanna
Palli, Domenico
Krogh, Vittorio
Ricceri, Fulvio
Rolandsson, Olov
Lu, Sai San Moon
Tsilidis, Konstantinos K.
Weiderpass, Elisabete
Gunter, Marc J.
Ferrari, Pietro
Berger, Ursula
Arnold, Melina
Funding for this research was provided by:
World Cancer Research Fund International (IIG_2016_1636, IIG_2016_1636, IIG_2016_1636, IIG_2019_1978, IIG_2016_1636)
Institut National Du Cancer (N°2020-087)
Article History
Received: 6 July 2021
Accepted: 11 April 2022
First Online: 14 May 2022
Declarations
:
: The study was approved by the Ethical Review Board of the International Agency for Research on Cancer (protocol numbers SC/24/4 and SC/24/6) and by the local Ethics Committees in the participating study centres. The EPIC cohort and projects undertaken within the EPIC cohort, were successfully re-evaluated by the IARC Ethics Committee (IEC, 2017). All study participants gave informed consent.
: Not applicable.
: The authors declare that they have no competing interests.